The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
Open accessAbstract
BACKGROUND: There is currently no licensed antiviral drug for treatment of dengue. Chloroquine (CQ) inhibits the replication of dengue virus (DENV) in vitro. METHODS AND FINDINGS: A double-blind, randomized, placebo-controlled trial of CQ in 307 adults hospitalized for suspected DENV infection was conducted at the Hospital for Tropical Diseases (Ho Chi Minh City, Vietnam) between May 2007 and July 2008. Patients with illness histories of 72 hours or less were randomized to a 3-day course of CQ (n = 153) or placebo (n = 154). Laboratory-confirmation of DENV infection was made in 257 (84%) patients. The primary endpoints were time to resolution of DENV viraemia and time to resolution of DENV NS1 antigenaemia. In patients treated with CQ there was a trend toward a longer duration of DENV viraemia (hazard ratio (HR) = 0.80, 95% CI 0.62-1.05), but we did not find any difference for the time to resolution of NS1 antigenaemia (HR = 1.07, 95% CI 0.76-1.51). Interestingly, CQ was associated with a significant reduction in fever clearance time in the intention-to-treat population (HR = 1.37, 95% CI 1.08-1.74) but not in the per-protocol population. There was also a trend towards a lower incidence of dengue hemorrhagic fever (odds ratio = 0.60, PP 95% CI 0.34-1.04) in patients treated with CQ. Differences in levels of T cell activation or pro- or anti-inflammatory plasma cytokine concentrations between CQ- and placebo-treated patients did not explain the trend towards less dengue hemorrhagic fever in the CQ arm. CQ was associated with significantly more adverse events, primarily vomiting. CONCLUSIONS: CQ does not reduce the durations of viraemia and NS1 antigenaemia in dengue patients. Further trials, with appropriate endpoints, would be required to determine if CQ treatment has any clinical benefit in dengue. TRIAL REGISTRATION: Current Controlled Trials number ISRCTN38002730.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632
Effects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268
Structure of the dengue virus envelope protein after membrane fusion
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2004) · Nature · doi:10.1038/nature02165 · Cited by 1,203
Libraty, D. H., Young, P. R., Pickering, D., Endy, T. P., Kalayanarooj, S., Green, S., Vaughn, D. W., Nisalak, A., Ennis, F. A., & Rothman, A. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/343813 · Cited by 739
Alcon, S., Talarmin, A., Debruyne, M., Falconar, A., Deubel, V., & Flamand, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.02.376-381.2002 · Cited by 686
Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation
Yu, I.-M., Zhang, W., Holdaway, H. A., Li, L., Kostyuchenko, V. A., Chipman, P. R., Kuhn, R. J., Rossmann, M. G., & Chen, J. (2008) · Science · doi:10.1126/science.1153264 · Cited by 623
Jessie, K., Fong, M. Y., Devi, S., Lam, S. K., & Wong, K. T. (2004) · The Journal of Infectious Diseases · doi:10.1086/383043 · Cited by 613
Lee, J., Chuang, T.-H., Redecke, V., She, L., Pitha, P. M., Carson, D. A., Raz, E., & Cottam, H. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631696100 · Cited by 592
Navarro‐Sanchez, E., Altmeyer, R., Amara, A., Schwartz, O., Fieschi, F., Virelizier, J., Arenzana‐Seisdedos, F., & Desprès, P. (2003) · EMBO reports · doi:10.1038/sj.embor.embor866 · Cited by 499
Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation
Yu, I.-M., Zhang, W., Holdaway, H. A., Li, L., Kostyuchenko, V. A., Chipman, P. R., Kuhn, R. J., Rossmann, M. G., & Chen, J. (2014) · Selected Papers of Michael G Rossmann with Commentaries · doi:10.1142/9789814513357_0047 · Cited by 436
Flamand, M., Mégret, F., Mathieu, M., Lepault, J., Rey, F. A., & Deubel, V. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6104-6110.1999 · Cited by 352
Jang, C.-H., Choi, J.-H., Byun, M.-S., & Jue, D.-M. (2006) · Rheumatology · doi:10.1093/rheumatology/kei282 · Cited by 305
Falconar, A. K. I. (1997) · Archives of Virology · doi:10.1007/s007050050127 · Cited by 296
Strategies for development of dengue virus inhibitors
Noble, C. G., Chen, Y.-L., Dong, H., Gu, F., Lim, S. P., Schul, W., Wang, Q.-Y., & Shi, P.-Y. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.12.011 · Cited by 276
Ty Hang, V., Minh Nguyet, N., The Trung, D., Tricou, V., Yoksan, S., Minh Dung, N., Van Ngoc, T., Hien, T. T., Farrar, J., Wills, B., et al. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000360 · Cited by 260
Self-citationOn Chikungunya Acute Infection and Chloroquine Treatment
Lamballerie, X. D., Boisson, V., Reynier, J.-C., Enault, S., Charrel, R. N., Flahault, A., Roques, P., & Grand, R. L. (2008) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2008.0049 · Cited by 245
Chloroquine enhances human CD8 + T cell responses against soluble antigens in vivo
Accapezzato, D., Visco, V., Francavilla, V., Molette, C., Donato, T., Paroli, M., Mondelli, M. U., Doria, M., Torrisi, M. R., & Barnaba, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051106 · Cited by 217
Acidotropic amines inhibit proteolytic processing of flavivirus prM protein
Randolph, V. B., Winkler, G., & Stollar, V. (1990) · Virology · doi:10.1016/0042-6822(90)90099-d · Cited by 202
Simmons, C. P., Popper, S., Dolocek, C., Chau, T. N. B., Griffiths, M., Dung, N. T. P., Long, T. H., Hoang, D. M., Chau, N. V., Thao, L. T. T., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512162 · Cited by 195
Self-citationCytokines, PGE2 and endotoxic fever: a re-assessment
Blatteis, C. M., Li, S., Li, Z., Feleder, C., & Perlík, V. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.01.001 · Cited by 177
Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control
Downs, W. G. (1987) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1987.36.670 · Cited by 152
Kyburz, D., Brentano, F., & Gay, S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0292 · Cited by 136
Immunology and Immunopathogenesis of Dengue Disease
Rothman, A. L. (2003) · Advances in virus research · doi:10.1016/s0065-3527(03)60010-2 · Cited by 132
Weber, S. M., & Levitz, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1534 · Cited by 129
Long term effectiveness of antimalarial drugs in rheumatic diseases
Aviña-Zubieta, J. A., Galindo-Rodríguez, G., Newman, S. C., Suarez-Almazor, M. E., & RUSSELL, A. S. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.10.582 · Cited by 120
da Silva, M. C. C., Guerrero-Plata, A., Gilfoy, F. D., Garofalo, R. P., & Mason, P. W. (2007) · Journal of Virology · doi:10.1128/jvi.00857-07 · Cited by 100
Confronting an influenza pandemic with inexpensive generic agents: can it be done?
Fedson, D. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70070-7 · Cited by 99
Zou, W., Amcheslavsky, A., & Bar‐Shavit, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212473200 · Cited by 97
A Complex Interplay among Virus, Dendritic Cells, T Cells, and Cytokines in Dengue Virus Infections
Dejnirattisai, W., Duangchinda, T., Lin, C.-L. S., Vasanawathana, S., Jones, M., Jacobs, M., Malasit, P., Xu, X., Screaton, G. R., & Mongkolsapaya, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5865 · Cited by 92
The Medicinal Chemistry of Dengue Fever
Stevens, A. J., Gahan, M. E., Mahalingam, S., & Keller, P. A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900652e · Cited by 89
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria
Rengelshausen, J., Burhenne, J., Fr�hlich, M., Tayrouz, Y., Singh, S. K., Riedel, K., M�ller, O., Hoppe‐Tichy, T., Haefeli, W. E., Mikus, G., et al. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0818-0 · Cited by 84
Ramı́rez, A., Moros, Z., Comach, G., et al. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.07.022 · Cited by 80
Antimalarial drugs for rheumatoid arthritis
Mackenzie, A. H. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90474-6 · Cited by 73
LACK OF A PHARMACOKINETIC INTERACTION BETWEEN AZITHROMYCIN AND CHLOROQUINE
Cook, J., Randinitis, E. J., Bramson, C., et al. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.407 · Cited by 59
Jeong, J., Choi, J. W., Jeon, K., & Jue, D. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01339.x · Cited by 41
Cited by
Simmons, C. P., Farrar, J. J., van Vinh Chau, N., & Wills, B. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1110265 · Cited by 1,732
Self-citationGuzman, M. G., & Harris, E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60572-9 · Cited by 1,345
Devaux, C. A., Rolain, J.-M., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,099
Guzman, M. G., Gubler, D. J., Izquierdo, A., Martinez, E., & Halstead, S. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.55 · Cited by 762
Molina, J. M., Delaugerre, C., Le Goff, J., Mela-Lima, B., Ponscarme, D., Goldwirt, L., & de Castro, N. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2020.03.006 · Cited by 749
Metadata
- Authors
- Tricou, V., Minh, N. N., Van, T. P., Lee, S. J., Farrar, J., Wills, B., Tran, H. T., & Simmons, C. P.
- Venue
- PLoS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-08-10
- Volume
- 4
- Issue
- 8
- Pages
- e785
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2006539971
- Cited by
- 329
- References
- 37
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.